Frankfurt am Main, Germany

Thibault Sauvaitre

USPTO Granted Patents = 1 

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thibault Sauvaitre: Innovator in Viral Disease Treatment

Introduction

Thibault Sauvaitre is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of viral diseases. His innovative work has led to the development of a unique compound that holds promise for medical applications.

Latest Patents

Sauvaitre holds a patent for "7-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease." This invention relates to a compound with a general formula (A), which may exist in various forms such as pharmaceutically acceptable salts, solvates, polymorphs, codrugs, cocrystals, prodrugs, tautomers, racemates, enantiomers, or diastereomers. The compound is designed to be useful in treating, ameliorating, or preventing viral diseases, and it also discloses specific combination therapies.

Career Highlights

Throughout his career, Thibault Sauvaitre has worked with prominent companies in the pharmaceutical industry. He has been associated with Savira Pharmaceuticals GmbH and F. Hoffmann-La Roche AG, where he has contributed to various research and development projects aimed at advancing medical treatments.

Collaborations

Sauvaitre has collaborated with notable colleagues, including Andrea Wolkerstorfer and Oliver Szolar. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the field.

Conclusion

Thibault Sauvaitre is a distinguished inventor whose work in developing treatments for viral diseases showcases his commitment to advancing medical science. His innovative patent and collaborations with leading companies and professionals highlight his significant contributions to the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…